View in EDS HTML Full Text PDF Full Text

Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial.
Authors: Gupta, Anil1 (AUTHOR), Perez-Rodríguez, Maria Teresa2 (AUTHOR), Gonzalez-Rojas, Yaneicy3 (AUTHOR), Ramgopal, Moti4 (AUTHOR), Free, Almena5 (AUTHOR), Han, Jennifer6,7 (AUTHOR) jennifer.8.han@gsk.com, Moore, Jennifer8 (AUTHOR), Givens, Naomi9 (AUTHOR), Yates, Phillip J.9 (AUTHOR), Walker, Jill T.6 (AUTHOR), Connolly, Mary Beth10 (AUTHOR), Schnell, Gretja11 (AUTHOR), Imber, Varsha8 (AUTHOR), Anselm, Rabia8 (AUTHOR), Winograd, Lindsay12 (AUTHOR), Segal, Scott6 (AUTHOR), Harrison, Stephen9 (AUTHOR), Skingsley, Andrew8 (AUTHOR), Aldinger, Melissa11 (AUTHOR), Peppercorn, Amanda6 (AUTHOR)
Source: Drugs in R&D. Dec2025, Vol. 25 Issue 4, p353-365. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11745886
DOI:10.1007/s40268-025-00529-2